相关实验视频

Updated: Jun 21, 2025

Exosomal miRNA Analysis in Non-small Cell Lung Cancer NSCLC Patients' Plasma Through qPCR: A Feasible Liquid Biopsy Tool

Exosomal miRNA Analysis in Non-small Cell Lung Cancer NSCLC Patients' Plasma Through qPCR: A Feasible Liquid Biopsy Tool

Published on: May 27, 2016

肺癌中的外体微RNA:叙事性综述

Zhe Zhang¹, Fengwu Lin¹, Wenqi Wu¹

¹Department of Thoracic Surgery, China-Japan Union Hospital of Jilin University, Changchun, China.

Translational cancer research

|July 11, 2024

概括

携带微RNA (miRNA) 的外体在肺癌进展中发挥着至关重要的作用,影响血管生成,侵袭和耐药性. 针对这些外体miRNAs为早期诊断和新型肺癌治疗提供了一个有前途的战略.

科学领域:

细胞生物学细胞生物学
分子瘤学分子瘤学
生物化学生物化学

背景情况:

外体是纳米级囊泡,通过转移微RNA (miRNA) 等生物活性分子来促进细胞间通信.
肺癌细胞分泌出含有miRNAs的外体,这些miRNAs对于细胞间信号传递至关重要.
miRNAs是非编码RNAs,可以在转录后调节基因表达.

研究的目的:

审查外体衍生的miRNAs在肺癌发育和进展中的多方面的作用.
探索外体miRNAs作为肺癌的诊断和预后生物标志物的潜力.
突出针对肺癌中外体miRNA的新型治疗策略.

主要方法:

文献审查,重点关注外体miRNA参与肺癌.
对外体miRNA在关键癌症过程中的作用的分析:血管新生,增殖,入侵,转移,免疫逃脱和耐药性.
评估外体miRNAs作为生物标记物的临床实用性.

主要成果:

外体miRNAs显著影响肺癌血管生成,表皮-介质细胞过渡和瘤微环境.
这些囊泡调解免疫逃生,并促进药物耐药性的传播.
外体miRNAs参与调节肺癌细胞增殖和转移.

结论:

外体miRNA为肺癌的发病和进展提供了新的见解.
向瘤特异性外体miRNAs为肺癌提供了一个新的治疗途径.
外体miRNAs作为早期肺癌诊断和预后的非侵入性生物标志物具有前途.

关键词:

外基因组是外基因组的组成部分.肺癌是一种肺癌.审查审查审查审查审查审查

更多相关视频

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening

Published on: October 26, 2017

Isolation and Profiling of MicroRNA-containing Exosomes from Human Bile

Isolation and Profiling of MicroRNA-containing Exosomes from Human Bile

Published on: June 13, 2016

相关概念视频

MicroRNAs

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...

lncRNA - Long Non-coding RNAs

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...

Overview of Exosomes

Overview of Exosomes

Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...

The Tumor Microenvironment

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...